101 related articles for article (PubMed ID: 17309603)
21. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
22. Oncoprotein v-Myb and retinoic acid receptor alpha are mutual antagonists.
Zemanová K; Smarda J
Blood Cells Mol Dis; 1998 Jun; 24(2):239-50. PubMed ID: 9714701
[TBL] [Abstract][Full Text] [Related]
23. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1.
Yoo YA; Kim MJ; Park JK; Chung YM; Lee JH; Chi SG; Kim JS; Yoo YD
Mol Cell Biol; 2005 Aug; 25(15):6603-16. PubMed ID: 16024796
[TBL] [Abstract][Full Text] [Related]
25. p53 induced growth arrest versus apoptosis and its modulation by survival cytokines.
Liebermann DA; Hoffman B; Vesely D
Cell Cycle; 2007 Jan; 6(2):166-70. PubMed ID: 17264673
[TBL] [Abstract][Full Text] [Related]
26. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
27. The homeobox gene GBX2, a target of the myb oncogene, mediates autocrine growth and monocyte differentiation.
Kowenz-Leutz E; Herr P; Niss K; Leutz A
Cell; 1997 Oct; 91(2):185-95. PubMed ID: 9346236
[TBL] [Abstract][Full Text] [Related]
28. c-Jun induces apoptosis of starved BM2 monoblasts by activating cyclin A-CDK2.
Vanhara P; Bryja V; Horváth V; Kozubík A; Hampl A; Smarda J
Biochem Biophys Res Commun; 2007 Feb; 353(1):92-7. PubMed ID: 17173865
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
30. Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.
Alli E; Yang JM; Hait WN
Oncogene; 2007 Feb; 26(7):1003-12. PubMed ID: 16909102
[TBL] [Abstract][Full Text] [Related]
31. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
32. Role of vimentin in regulation of monocyte/macrophage differentiation.
Benes P; Macecková V; Zdráhal Z; Konecná H; Zahradnícková E; Muzík J; Smarda J
Differentiation; 2006 Jul; 74(6):265-76. PubMed ID: 16831196
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the molecular mechanisms for p53-mediated differentiation.
Chylicki K; Ehinger M; Svedberg H; Gullberg U
Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
[TBL] [Abstract][Full Text] [Related]
34. A dual activation mechanism for Myb-responsive genes in myelomonocytic cells.
Yamkamon V; Ivanova O; Braas D; Chayka O; Patmasiriwat P; Klempnauer KH
Blood Cells Mol Dis; 2008; 40(2):219-26. PubMed ID: 17950008
[TBL] [Abstract][Full Text] [Related]
35. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
36. Avian myeloblastic cell lines transformed by two nuclear oncoproteins, P135gag-myb-ets and p61/63myc: a model of retinoic acid-induced differentiation not abrogated by v-erbA.
al Moustafa AE; Gautier R; Saule S; Dieterlen-Lièvre F; Cormier F
Cell Growth Differ; 1994 Aug; 5(8):863-71. PubMed ID: 7986751
[TBL] [Abstract][Full Text] [Related]
37. v-Myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of human promonocytic U937 cells.
Knopfova L; Smarda J
Neoplasma; 2008; 55(4):286-93. PubMed ID: 18505338
[TBL] [Abstract][Full Text] [Related]
38. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
39. An ex vivo model to study v-Myb-induced leukemogenicity.
Dvorakova M; Kralova J; Karafiat V; Bartunek P; Dvorak M
Blood Cells Mol Dis; 2001; 27(2):437-45. PubMed ID: 11259166
[TBL] [Abstract][Full Text] [Related]
40. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
